Grants

Michele Galizia, Ph.D., an assistant professor in the Gallogly College of Engineering at the University of Oklahoma, has received a 2021 National Science Foundation Early CAREER Development grant to continue his research focusing on membrane technology, a technique that separates molecules from mixtures by size and shape. About 10% of global energy consumption is devoted to these chemical separations and enhancing the energy efficiency of industrial separations is crucial to decreasing costs and controlling environmental pollution.

Bradley received a nearly $4 million grant from the National Cancer Institute to study ways to lessen the impacts of stress specifically on cancer caregivers who are also employed.

Damon Runyon Cancer Research Foundation has announced the 2021 recipients of the Damon Runyon Clinical Investigator award--six outstanding early career physician-scientists working to develop new cancer therapies under the mentorship of the nation's leading scientists and clinicians.

NanED is a Marie-Sklodowska-Curie Action project that will involve 15 Ph.D. students to participate to an innovative training network dedicated to 3D electron diffraction. Young researchers will learn from experts in Europe and a pool of companies coming from different fields in order to create the future generation of electron crystallographers that will make Europe the world leader in nanomaterial characterisation. The project's consortium is led by IIT-Istituto italiano di Tecnologia.

Children's National Hospital announces a $12.8 million award from the National Institutes of Health's National Human Genome Research Institute (NHGRI) to establish the only Pediatric Mendelian Genomics Research Center (PMGRC) as part of a new Mendelian Genomics Research Consortium. Researchers at Children's National and Invitae -- a leading medical genetics company -- will identify novel causes of rare inherited diseases, investigate the mechanisms of undiagnosed conditions, enhance data sharing, and generally interrogate Mendelian phenotypes, which are conditions that run in families.

The Lott's $600,000 contribution will be used to enhance the research capabilities of the Zero Childhood Cancer Program, to give every child with cancer in Australia the very best chance of survival.